Title: Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
Authors: Raju, Sharat C; Hauff, Samantha J; Lemieux, Aaron J; Orosco, Ryan K; Gross, Andrew M; Nguyen, Linda T; Savariar, Elamprakash; Moss, William; Whitney, Michael; Cohen, Ezra E; Lippman, Scott M; Tsien, Roger Y; Ideker, Trey; Advani, Sunil J; Nguyen, Quyen T
Published In Oral Oncol, (2015 May)
Abstract: Patients with head and neck squamous cell carcinoma (HNSCC) containing TP53 mutation and 3p deletion ("double-hit") have poorer prognosis compared to patients with either event alone ("single-hit"). The etiology for worse clinical outcomes in patients with "double-hit" cancers is unclear. We compared radiosensitivity of cell lines containing both TP53 mutations and deletion of Fragile Histidine Triad (FHIT, the gene most commonly associated with 3p deletion) to "single-hit" lines with only TP53 mutation. We compared radiosensitivity in a "single-hit" cell line with TP53 mutation converted to "double-hit" using RNA interference targeting FHIT. Finally, we compared matrixmetalloproteinase-2/9 (MMP-2/9) activity, a previously-established biomarker for tumor aggressiveness, in xenograft tumors derived from these cell lines.TP53 mutation and FHIT deletion profiles of HNSCC lines were established using Cancer Cell Line Encyclopedia (CCLE). We used RNA-interference to convert a "single-hit" cell line (SCC4) to "double-hit". Cultured cells were examined for radiosensitivity and cisplatin sensitivity. MMP-2/9 activity was evaluated in "double-hit" versus "single-hit" tumors using ratiometric activatable cell-penetrating peptide (RACPP) in tongue (n=17) and flank xenografts (n=4).Radiotherapy caused greater double-stranded DNA breaks in "single-hit" vs naturally occurring and engineered "double-hit" cells. In-vivo, "double-hit" xenografts demonstrated higher MMP-2/9 activity compared to "single-hit" xenografts (p<0.01). There was no difference in cisplatin sensitivity between the cell lines.TP53 mutation combined with FHIT deletion correlates with decreased radiosensitivity in HNC cell lines. Xenograft from "double-hit" cells exhibit increased MMP-2/9 activity. These findings may in part account for the worse clinical outcome seen in patients with HNSCC "double-hit" tumors.
PubMed ID: 25735654
MeSH Terms: Acid Anhydride Hydrolases/genetics; Carcinoma, Squamous Cell/enzymology; Carcinoma, Squamous Cell/genetics*; Carcinoma, Squamous Cell/radiotherapy; Cell Line, Tumor; Chromosome Deletion*; Chromosomes, Human, Pair 3*; Genes, p53*; Head and Neck Neoplasms/enzymology; Head and Neck Neoplasms/genetics*; Head and Neck Neoplasms/radiotherapy; Humans; Matrix Metalloproteinases/metabolism*; Mutation; Neoplasm Proteins/genetics; Radiation Tolerance